Naveed Sattar

Top papers

• 2016 European Guidelines on cardiovascular disease prevention in clinical practice

  Massimo Piepoli, Arno W. Hoes, Stefan Agewall, et al.·2016·European Heart Journal
  ↗ 6,463OA
• 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

  Frank L.J. Visseren, François Mach, Yvo M. Smulders, et al.·2021·European Heart Journal
  ↗ 6,063OA
• Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

  Milton Packer, Stefan D. Anker, Javed Butler, et al.·2020·New England Journal of Medicine
  ↗ 4,904OA
• 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

  Francesco Cosentino, Peter J Grant, Victor Aboyans, et al.·2019·European Heart Journal
  ↗ 4,837OA
• Empagliflozin in Heart Failure with a Preserved Ejection Fraction

  Stefan D. Anker, Javed Butler, Gerasimos Filippatos, et al.·2021·New England Journal of Medicine
  ↗ 4,461OA
• Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents

  Emanuele Di Angelantonio, Shilpa N Bhupathiraju, David Wormser, et al.·2016·The Lancet
  ↗ 2,772OA
• Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death

  Sreenivasa Rao Kondapally Seshasai, Stephen Kaptoge, Alexander Thompson, et al.·2011·New England Journal of Medicine
  ↗ 2,728OA
• Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

  Naveed Sattar, David Preiss, Heather Murray, et al.·2010·The Lancet
  ↗ 2,436
• Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial

  Michael EJ Lean, W. S. Leslie, Alison C. Barnes, et al.·2017·The Lancet
  ↗ 2,017OA
• ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

  Authors Task Force Members, Lars Rydén, Peter J. Grant, et al.·2013·European Heart Journal
  ↗ 1,953OA
• Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps

  Anubha Mahajan, Daniel Taliun, Matthias Thurner, et al.·2018·Nature Genetics
  ↗ 1,909OA
• Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

  Søren Lund Kristensen, Rasmus Rørth, Pardeep S. Jhund, et al.·2019·The Lancet Diabetes & Endocrinology
  ↗ 1,570OA